tradingkey.logo

Teladoc Health Inc

TDOC
7.455USD
-0.155-2.04%
收盘 01/09, 16:00美东报价延迟15分钟
1.32B总市值
亏损市盈率 TTM

Teladoc Health Inc

7.455
-0.155-2.04%

关于 Teladoc Health Inc 公司

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

Teladoc Health Inc简介

公司代码TDOC
公司名称Teladoc Health Inc
上市日期Jul 01, 2015
CEODivita (Charles III)
员工数量5500
证券类型Ordinary Share
年结日Jul 01
公司地址155 E 44Th Street
城市NEW YORK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编10017
电话12036352002
网址https://www.teladochealth.com/
公司代码TDOC
上市日期Jul 01, 2015
CEODivita (Charles III)

Teladoc Health Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
201.04K
+22022.00%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
80.73K
+5553.00%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
60.05K
+4953.00%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+17467.00%
Mr. Kenneth H. (Ken) Paulus
Mr. Kenneth H. (Ken) Paulus
Independent Director
Independent Director
10.00K
+10000.00%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Catherine A. Jacobson
Ms. Catherine A. Jacobson
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
201.04K
+22022.00%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
80.73K
+5553.00%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
60.05K
+4953.00%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+17467.00%
Mr. Kenneth H. (Ken) Paulus
Mr. Kenneth H. (Ken) Paulus
Independent Director
Independent Director
10.00K
+10000.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
业务USD
名称
营收
占比
Access Fees Revenue
520.91M
83.15%
Other
105.53M
16.85%
地区USD
名称
营收
占比
United States
509.77M
81.38%
International
116.67M
18.62%
业务
地区
业务USD
名称
营收
占比
Access Fees Revenue
520.91M
83.15%
Other
105.53M
16.85%

股东统计

更新时间: 12月15日 周一
更新时间: 12月15日 周一
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.29%
BlackRock Institutional Trust Company, N.A.
6.91%
Renaissance Technologies LLC
4.61%
Dimensional Fund Advisors, L.P.
3.88%
Point72 Asset Management, L.P.
3.25%
其他
69.06%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.29%
BlackRock Institutional Trust Company, N.A.
6.91%
Renaissance Technologies LLC
4.61%
Dimensional Fund Advisors, L.P.
3.88%
Point72 Asset Management, L.P.
3.25%
其他
69.06%
股东类型
持股股东
占比
Investment Advisor
31.28%
Investment Advisor/Hedge Fund
19.60%
Hedge Fund
14.46%
Research Firm
5.08%
Individual Investor
1.13%
Bank and Trust
0.79%
Pension Fund
0.54%
Family Office
0.14%
Sovereign Wealth Fund
0.10%
其他
26.88%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
925
127.72M
72.01%
-41.66M
2025Q3
959
134.32M
75.74%
-32.25M
2025Q2
998
134.63M
76.20%
-42.03M
2025Q1
1041
132.44M
75.49%
-42.98M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
21.80M
12.29%
+891.73K
+4.27%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.25M
6.91%
+41.01K
+0.34%
Sep 30, 2025
Renaissance Technologies LLC
8.18M
4.61%
+855.30K
+11.68%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
6.89M
3.88%
+1.33M
+23.82%
Sep 30, 2025
Point72 Asset Management, L.P.
5.76M
3.25%
-2.08M
-26.49%
Sep 30, 2025
State Street Investment Management (US)
4.66M
2.63%
-318.88K
-6.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
4.17M
2.35%
+19.72K
+0.48%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.03M
1.71%
+1.61M
+114.24%
Sep 30, 2025
Two Sigma Investments, LP
2.57M
1.45%
-2.45M
-48.83%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
2.54M
1.43%
-99.28K
-3.76%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X HealthTech ETF
1.27%
First Trust Indxx Metaverse ETF
1.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.65%
Principal U.S. Small-Cap ETF
0.46%
Langar Global HealthTech ETF
0.38%
First Trust Small Cap Value AlphaDEX Fund
0.29%
iShares U.S. Healthcare Providers ETF
0.24%
Optimize Strategy Index ETF
0.24%
Fidelity Enhanced Small Cap ETF
0.2%
State Street SPDR S&P Kensho New Econ Comp ETF
0.18%
查看更多
Global X HealthTech ETF
占比1.27%
First Trust Indxx Metaverse ETF
占比1.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.65%
Principal U.S. Small-Cap ETF
占比0.46%
Langar Global HealthTech ETF
占比0.38%
First Trust Small Cap Value AlphaDEX Fund
占比0.29%
iShares U.S. Healthcare Providers ETF
占比0.24%
Optimize Strategy Index ETF
占比0.24%
Fidelity Enhanced Small Cap ETF
占比0.2%
State Street SPDR S&P Kensho New Econ Comp ETF
占比0.18%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Teladoc Health Inc的前五大股东是谁?

Teladoc Health Inc 的前五大股东如下:
The Vanguard Group, Inc.持有股份:21.80M,占总股份比例:12.29%。
BlackRock Institutional Trust Company, N.A.持有股份:12.25M,占总股份比例:6.91%。
Renaissance Technologies LLC持有股份:8.18M,占总股份比例:4.61%。
Dimensional Fund Advisors, L.P.持有股份:6.89M,占总股份比例:3.88%。
Point72 Asset Management, L.P.持有股份:5.76M,占总股份比例:3.25%。

Teladoc Health Inc的前三大股东类型是什么?

Teladoc Health Inc 的前三大股东类型分别是:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC

有多少机构持有Teladoc Health Inc(TDOC)的股份?

截至2025Q4,共有925家机构持有Teladoc Health Inc的股份,合计持有的股份价值约为127.72M,占公司总股份的72.01%。与2025Q3相比,机构持股有所增加,增幅为-3.72%。

哪个业务部门对Teladoc Health Inc的收入贡献最大?

在FY2025Q3,Access Fees Revenue业务部门对Teladoc Health Inc的收入贡献最大,创收520.91M,占总收入的83.15%。
KeyAI